GENI vs. DIS, AMC, LION, SPHR, GVC, SONG, TKO, NFC, MCS, and RDI
Should you be buying GENinCode stock or one of its competitors? The main competitors of GENinCode include Distil (DIS), Amur Minerals (AMC), Lionsgold (LION), Sphere Medical (SPHR), Entain PLC (GVC.L) (GVC), Hipgnosis Songs (SONG), Taseko Mines (TKO), Next Fifteen Communications Group (NFC), McCarthy & Stone (MCS), and Rdi Reit (RDI). These companies are all part of the "entertainment" industry.
GENinCode vs. Its Competitors
GENinCode (LON:GENI) and Distil (LON:DIS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations, institutional ownership and risk.
Distil has a net margin of -109.66% compared to GENinCode's net margin of -228.70%. Distil's return on equity of -22.94% beat GENinCode's return on equity.
In the previous week, Distil had 1 more articles in the media than GENinCode. MarketBeat recorded 1 mentions for Distil and 0 mentions for GENinCode. GENinCode's average media sentiment score of 0.00 equaled Distil'saverage media sentiment score.
GENinCode has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, Distil has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500.
Distil received 39 more outperform votes than GENinCode when rated by MarketBeat users.
Distil has lower revenue, but higher earnings than GENinCode. Distil is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.
47.6% of GENinCode shares are owned by institutional investors. Comparatively, 0.0% of Distil shares are owned by institutional investors. 39.8% of GENinCode shares are owned by insiders. Comparatively, 60.2% of Distil shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Distil beats GENinCode on 9 of the 13 factors compared between the two stocks.
Get GENinCode News Delivered to You Automatically
Sign up to receive the latest news and ratings for GENI and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
GENinCode Competitors List
Related Companies and Tools
This page (LON:GENI) was last updated on 6/13/2025 by MarketBeat.com Staff
Buy GENI Stock Free GENI Stock Alerts